{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:39:36Z","timestamp":1788057576452,"version":"build-2784847793"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R&D Program of China Grants","award":["2018YFA0109800"],"award-info":[{"award-number":["2018YFA0109800"]}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["No.2019M652328"],"award-info":[{"award-number":["No.2019M652328"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Natural Science Foundation grant","award":["ZR2022MH183"],"award-info":[{"award-number":["ZR2022MH183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adipose tissue-derived stem cell (ADSC) transplantation has been shown to be effective for the management of severe liver disorders. Preactivation of ADSCs enhanced their therapeutic efficacy. However, these effects have not yet been examined in relation to cholestatic liver injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present study, a cholestatic liver injury model was established by bile duct ligation (BDL) in male C57BL\/6 mice. Human ADSCs (hADSCs) with or without tumor necrosis factor-alpha (TNF-\u03b1) and interleukin-1beta (IL-1\u03b2) pretreatment were administrated into the mice via tail vein injections. The efficacy of hADSCs on BDL-induced liver injury was assessed by histological staining, real-time quantitative PCR (RT-qPCR), Western blot, and enzyme-linked immune sorbent assay (ELISA). In vitro, the effects of hADSC conditioned medium on the activation of hepatic stellate cells (HSCs) were investigated. Small interfering RNA (siRNA) was used to knock down cyclooxygenase-2 (COX-2) in hADSCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TNF-\u03b1\/IL-1\u03b2 preconditioning could downregulate immunogenic gene expression and enhance the engraftment efficiency of hADSCs. Compared to control hADSCs (C-hADSCs), TNF-\u03b1\/IL-1\u03b2-pretreated hADSCs (P-hADSCs) significantly alleviated BDL-induced liver injury, as demonstrated by reduced hepatic cell death, attenuated infiltration of Ly6G\u2009+\u2009neutrophils, and decreased expression of pro-inflammatory cytokines TNF-\u03b1, IL-1\u03b2, C-X-C motif chemokine ligand 1 (CXCL1), and C-X-C motif chemokine ligand 2 (CXCL2). Moreover, P-hADSCs significantly delayed the development of BDL-induced liver fibrosis. In vitro, conditioned medium from P-hADSCs significantly inhibited HSC activation compared to that from C-hADSCs. Mechanistically, TNF-\u03b1\/IL-1\u03b2 upregulated COX-2 expression and increased prostaglandin E2 (PGE2) secretion. The blockage of COX-2 by siRNA transfection reversed the benefits of P-hADSCs for PGE2 production, HSC activation, and liver fibrosis progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, our results suggest that TNF-\u03b1\/IL-1\u03b2 pretreatment enhances the efficacy of hADSCs in mice with cholestatic liver injury, partially through the COX-2\/PGE2 pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-023-03342-3","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:02:53Z","timestamp":1682337773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["TNF-\u03b1\/IL-1\u03b2-licensed hADSCs alleviate cholestatic liver injury and fibrosis in mice via COX-2\/PGE2 pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Xiaoyu","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-730X","authenticated-orcid":false,"given":"Guohu","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"issue":"3","key":"3342_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","volume":"67","author":"P Fickert","year":"2017","unstructured":"Fickert P, Wagner M. Biliary bile acids in hepatobiliary injury: what is the link? J Hepatol. 2017;67(3):619\u201331.","journal-title":"J Hepatol"},{"issue":"3","key":"3342_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3727\/105221619X15614873062730","volume":"19","author":"BL Woolbright","year":"2019","unstructured":"Woolbright BL, Jaeschke H. Inflammation and cell death during cholestasis: the evolving role of bile acids. Gene Expr. 2019;19(3):215\u201328.","journal-title":"Gene Expr"},{"issue":"1 Suppl","key":"3342_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0168-8278(00)80421-3","volume":"32","author":"R Poupon","year":"2000","unstructured":"Poupon R, Chazouill\u00e8res O, Poupon RE. Chronic cholestatic diseases. J Hepatol. 2000;32(1 Suppl):129\u201340.","journal-title":"J Hepatol"},{"issue":"5","key":"3342_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","volume":"139","author":"GM Hirschfield","year":"2010","unstructured":"Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010;139(5):1481\u201396.","journal-title":"Gastroenterology"},{"issue":"5","key":"3342_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90780","volume":"2","author":"SY Cai","year":"2017","unstructured":"Cai SY, Ouyang X, Chen Y, Soroka CJ, Wang J, Mennone A, et al. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. JCI insight. 2017;2(5): e90780.","journal-title":"JCI insight"},{"issue":"5","key":"3342_CR6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/hep.30706","volume":"70","author":"N Jalan-Sakrikar","year":"2019","unstructured":"Jalan-Sakrikar N, De Assuncao TM, Shi G, Aseem SO, Chi C, Shah VH, et al. Proteasomal degradation of enhancer of zeste homologue 2 in cholangiocytes promotes biliary fibrosis. Hepatology (Baltimore, MD). 2019;70(5):1674\u201389.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"3342_CR7","first-page":"237","volume":"9","author":"M Sellinger","year":"1990","unstructured":"Sellinger M, Boyer JL. Physiology of bile secretion and cholestasis. Prog Liver Dis. 1990;9:237\u201359.","journal-title":"Prog Liver Dis"},{"issue":"4","key":"3342_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","volume":"44","author":"A Bertolini","year":"2022","unstructured":"Bertolini A, Fiorotto R, Strazzabosco M. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation. Semin Immunopathol. 2022;44(4):547\u201364.","journal-title":"Semin Immunopathol"},{"issue":"2","key":"3342_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PL Jansen","year":"2017","unstructured":"Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, et al. The ascending pathophysiology of cholestatic liver disease. Hepatology (Baltimore, MD). 2017;65(2):722\u201338.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"3342_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/hep.30213","volume":"69","author":"A Ghallab","year":"2019","unstructured":"Ghallab A, Hofmann U, Sezgin S, Vartak N, Hassan R, Zaza A, et al. Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood. Hepatology (Baltimore, MD). 2019;69(2):666\u201383.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"10","key":"3342_CR11","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.3390\/cells10102618","volume":"10","author":"TM Holtmann","year":"2021","unstructured":"Holtmann TM, Inzaugarat ME, Knorr J, Geisler L, Schulz M, Bieghs V, et al. Bile acids activate NLRP3 inflammasome, promoting murine liver inflammation or fibrosis in a cell type-specific manner. Cells. 2021;10(10):2618.","journal-title":"Cells"},{"issue":"9","key":"3342_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","volume":"100","author":"JM Gimble","year":"2007","unstructured":"Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249\u201360.","journal-title":"Circ Res"},{"issue":"38","key":"3342_CR13","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.3748\/wjg.v23.i38.6973","volume":"23","author":"LJ Xu","year":"2017","unstructured":"Xu LJ, Wang SF, Wang DQ, Ma LJ, Chen Z, Chen QQ, et al. Adipose-derived stromal cells resemble bone marrow stromal cells in hepatocyte differentiation potential in vitro and in vivo. World J Gastroenterol. 2017;23(38):6973\u201382.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3342_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13287-019-1177-1","volume":"10","author":"J Jin","year":"2019","unstructured":"Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, et al. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019;10(1):95.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3342_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s13287-020-02015-9","volume":"11","author":"Y Mizuta","year":"2020","unstructured":"Mizuta Y, Akahoshi T, Guo J, Zhang S, Narahara S, Kawano T, et al. Exosomes from adipose tissue-derived mesenchymal stem cells ameliorate histone-induced acute lung injury by activating the PI3K\/Akt pathway in endothelial cells. Stem Cell Res Ther. 2020;11(1):508.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3342_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-021-02287-9","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhao B, Zhang XL, Lu YJ, Lu ST, Cheng J, et al. Combined topical and systemic administration with human adipose-derived mesenchymal stem cells (hADSC) and hADSC-derived exosomes markedly promoted cutaneous wound healing and regeneration. Stem Cell Res Ther. 2021;12(1):257.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3342_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s13287-021-02625-x","volume":"12","author":"CH Zhu","year":"2021","unstructured":"Zhu CH, Zhang DH, Zhu CW, Xu J, Guo CL, Wu XG, et al. Adult stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a systematic review and meta-analysis. Stem Cell Res Ther. 2021;12(1):558.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3342_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jfma.2012.12.002","volume":"114","author":"F Yu","year":"2015","unstructured":"Yu F, Ji S, Su L, Wan L, Zhang S, Dai C, et al. Adipose-derived mesenchymal stem cells inhibit activation of hepatic stellate cells in\u00a0vitro and ameliorate rat liver fibrosis in\u00a0vivo. J Formosan Med Assoc. 2015;114(2):130\u20138.","journal-title":"J Formosan Med Assoc"},{"issue":"1","key":"3342_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-019-1310-1","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Li L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther. 2019;10(1):199.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3342_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s13287-022-03049-x","volume":"13","author":"B Wu","year":"2022","unstructured":"Wu B, Feng J, Guo J, Wang J, Xiu G, Xu J, et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. Stem Cell Res Ther. 2022;13(1):494.","journal-title":"Stem Cell Res Ther"},{"key":"3342_CR21","doi-asserted-by":"publisher","first-page":"5858247","DOI":"10.1155\/2019\/5858247","volume":"2019","author":"M Patrikoski","year":"2019","unstructured":"Patrikoski M, Mannerstr\u00f6m B, Miettinen S. Perspectives for clinical translation of adipose stromal\/stem cells. Stem Cells Int. 2019;2019:5858247.","journal-title":"Stem Cells Int"},{"issue":"9","key":"3342_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cells11091376","volume":"11","author":"RM Wise","year":"2022","unstructured":"Wise RM, Al-Ghadban S, Harrison MAA, Sullivan BN, Monaco ER, Aleman SJ, et al. Short-term autophagy preconditioning upregulates the expression of COX2 and PGE2 and alters the immune phenotype of human adipose-derived stem cells in vitro. Cells. 2022;11(9):1376.","journal-title":"Cells"},{"issue":"6","key":"3342_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41419-021-03883-6","volume":"12","author":"Y Fu","year":"2021","unstructured":"Fu Y, Sui B, Xiang L, Yan X, Wu D, Shi S, et al. Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy. Cell Death Dis. 2021;12(6):596.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3342_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jcmm.14788","volume":"24","author":"C Hu","year":"2020","unstructured":"Hu C, Wu Z, Li L. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med. 2020;24(1):40\u20139.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3342_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-020-01763-y","volume":"11","author":"N Liao","year":"2020","unstructured":"Liao N, Shi Y, Wang Y, Liao F, Zhao B, Zheng Y, et al. Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model. Stem Cell Res Ther. 2020;11(1):237.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"3342_CR26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101868RRR","volume":"36","author":"J Xu","year":"2022","unstructured":"Xu J, Chen P, Yu C, Shi Q, Wei S, Li Y, et al. Hypoxic bone marrow mesenchymal stromal cells-derived exosomal miR-182-5p promotes liver regeneration via FOXO1-mediated macrophage polarization. FASEB J. 2022;36(10): e22553.","journal-title":"FASEB J"},{"issue":"4","key":"3342_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.kint.2017.08.030","volume":"93","author":"M Bai","year":"2018","unstructured":"Bai M, Zhang L, Fu B, Bai J, Zhang Y, Cai G, et al. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2\/PGE2 pathway. Kidney Int. 2018;93(4):814\u201325.","journal-title":"Kidney Int"},{"issue":"9","key":"3342_CR28","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.ymthe.2020.05.023","volume":"28","author":"K Lynch","year":"2020","unstructured":"Lynch K, Treacy O, Chen X, Murphy N, Lohan P, Islam MN, et al. TGF-\u03b21-licensed murine MSCs show superior therapeutic efficacy in modulating corneal allograft immune rejection in vivo. Mol Ther J Am Soc Gene Ther. 2020;28(9):2023\u201343.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"16","key":"3342_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202107354","volume":"18","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang Z, Wang B, Dong Y, Zhao C, Zhao Y, et al. Inflammation-stimulated MSC-derived small extracellular vesicle miR-27b-3p regulates macrophages by targeting CSF-1 to promote temporomandibular joint condylar regeneration. Small. 2022;18(16): e2107354.","journal-title":"Small"},{"issue":"17","key":"3342_CR30","doi-asserted-by":"publisher","first-page":"9531","DOI":"10.3390\/ijms22179531","volume":"22","author":"L L\u00f3pez-Garc\u00eda","year":"2021","unstructured":"L\u00f3pez-Garc\u00eda L, Castro-Manrreza ME. TNF-\u03b1 and IFN-\u03b3 participate in improving the immunoregulatory capacity of mesenchymal stem\/stromal cells: importance of cell-cell contact and extracellular vesicles. Int J Mol Sci. 2021;22(17):9531.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3342_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13287-020-02118-3","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang S, Fang J, Liu Z, Hou P, Cao L, Zhang Y, et al. Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis. Stem Cell Res Ther. 2021;12(1):50.","journal-title":"Stem Cell Res Ther"},{"key":"3342_CR32","doi-asserted-by":"publisher","first-page":"2803747","DOI":"10.1155\/2020\/2803747","volume":"2020","author":"L Liu","year":"2020","unstructured":"Liu L, He YR, Liu SJ, Hu L, Liang LC, Liu DL, et al. Enhanced effect of IL-1\u03b2-activated adipose-derived MSCs (ADMSCs) on repair of intestinal ischemia-reperfusion injury via COX-2-PGE(2) signaling. Stem Cells Int. 2020;2020:2803747.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3342_CR33","doi-asserted-by":"publisher","first-page":"14521","DOI":"10.1038\/s41598-020-71337-8","volume":"10","author":"C Yu","year":"2020","unstructured":"Yu C, Chen P, Xu J, Liu Y, Li H, Wang L, et al. hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye. Sci Rep. 2020;10(1):14521.","journal-title":"Sci Rep"},{"issue":"5","key":"3342_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1177\/08853282221121861","volume":"37","author":"Q Shi","year":"2022","unstructured":"Shi Q, Wei S, Li ZC, Xu J, Li Y, Guo C, et al. Collagen-binding fibroblast growth factor ameliorates liver fibrosis in murine bile duct ligation injury. J Biomater Appl. 2022;37(5):918\u201329.","journal-title":"J Biomater Appl"},{"issue":"2","key":"3342_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.18240\/ijo.2021.02.01","volume":"14","author":"GH Di","year":"2021","unstructured":"Di GH, Qi X, Xu J, Yu CQ, Cao QL, Xing ZJ, et al. Therapeutic effect of secretome from TNF-\u03b1 stimulated mesenchymal stem cells in an experimental model of corneal limbal stem cell deficiency. Int J Ophthalmol. 2021;14(2):179\u201385.","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"3342_CR36","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.stem.2022.10.001","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Fang J, Liu B, Shao C, Shi Y. Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 2022;29(11):1515\u201330.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"3342_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.transproceed.2006.12.019","volume":"39","author":"S Schrepfer","year":"2007","unstructured":"Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transpl Proc. 2007;39(2):573\u20136.","journal-title":"Transpl Proc"},{"issue":"4","key":"3342_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/biores.2014.0012","volume":"3","author":"S Sart","year":"2014","unstructured":"Sart S, Ma T, Li Y. Preconditioning stem cells for in vivo delivery. BioResearch Open Access. 2014;3(4):137\u201349.","journal-title":"BioResearch Open Access"},{"key":"3342_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/632902","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee S, Choi E, Cha MJ, Hwang KC. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxid Med Cell Longev. 2015;2015: 632902.","journal-title":"Oxid Med Cell Longev"},{"key":"3342_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.933565","volume":"10","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhao RC, Zhang F. Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives. Front Cell Dev Biol. 2022;10: 933565.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3342_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40659-018-0191-6","volume":"51","author":"DS Chae","year":"2018","unstructured":"Chae DS, Lee CY, Lee J, Seo HH, Choi CH, Lee S, et al. Priming stem cells with protein kinase C activator enhances early stem cell-chondrocyte interaction by increasing adhesion molecules. Biol Res. 2018;51(1):41.","journal-title":"Biol Res"},{"issue":"10","key":"3342_CR42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringd\u00e9n O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31(10):890\u20136.","journal-title":"Exp Hematol"},{"issue":"3","key":"3342_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252\u201360.","journal-title":"Nat Biotechnol"},{"key":"3342_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785717","volume":"12","author":"JM Chen","year":"2021","unstructured":"Chen JM, Huang QY, Zhao YX, Chen WH, Lin S, Shi QY. The latest developments in immunomodulation of mesenchymal stem cells in the treatment of intrauterine adhesions, both allogeneic and autologous. Front Immunol. 2021;12: 785717.","journal-title":"Front Immunol"},{"issue":"5","key":"3342_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012;10(5):544\u201355.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"3342_CR46","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3727\/096368914X681748","volume":"24","author":"O Ham","year":"2015","unstructured":"Ham O, Lee SY, Song BW, Cha MJ, Lee CY, Park JH, et al. Modulation of Fas\u2013Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche. Cell Transplant. 2015;24(7):1329\u201341.","journal-title":"Cell Transplant"},{"key":"3342_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai SY, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Asp Med. 2017;56:45\u201353.","journal-title":"Mol Asp Med"},{"issue":"2","key":"3342_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/jhep.2003.50341","volume":"38","author":"JS Gujral","year":"2003","unstructured":"Gujral JS, Farhood A, Bajt ML, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology (Baltimore, MD). 2003;38(2):355\u201363.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"3","key":"3342_CR49","doi-asserted-by":"publisher","first-page":"G499","DOI":"10.1152\/ajpgi.00318.2003","volume":"286","author":"JS Gujral","year":"2004","unstructured":"Gujral JS, Liu J, Farhood A, Hinson JA, Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol. 2004;286(3):G499-507.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"3342_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","volume":"32","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Hong JY, Rockwell CE, Copple BL, Jaeschke H, Klaassen CD. Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int. 2012;32(1):58\u201369.","journal-title":"Liver Int"},{"issue":"1","key":"3342_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011;178(1):175\u201386.","journal-title":"Am J Pathol"},{"issue":"4","key":"3342_CR52","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/hep.32492","volume":"76","author":"NH Mohamad Zaki","year":"2022","unstructured":"Mohamad Zaki NH, Shiota J, Calder AN, Keeley TM, Allen BL, Nakao K, et al. C-X-C motif chemokine ligand 1 induced by Hedgehog signaling promotes mouse extrahepatic bile duct repair after acute injury. Hepatology (Baltimore, MD). 2022;76(4):936\u201350.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"3342_CR53","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/toxsci\/kfj111","volume":"90","author":"ND Kim","year":"2006","unstructured":"Kim ND, Moon JO, Slitt AL, Copple BL. Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci. 2006;90(2):586\u201395.","journal-title":"Toxicol Sci"},{"issue":"1","key":"3342_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.taap.2009.11.013","volume":"243","author":"K Allen","year":"2010","unstructured":"Allen K, Kim ND, Moon JO, Copple BL. Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol. 2010;243(1):63\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"3342_CR55","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","volume":"11","author":"P An","year":"2020","unstructured":"An P, Wei LL, Zhao S, Sverdlov DY, Vaid KA, Miyamoto M, et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun. 2020;11(1):2362.","journal-title":"Nat Commun"},{"issue":"5","key":"3342_CR56","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jcmgh.2022.01.015","volume":"13","author":"M Sojoodi","year":"2022","unstructured":"Sojoodi M, Erstad DJ, Barrett SC, Salloum S, Zhu S, Qian T, et al. Peroxidasin deficiency re-programs macrophages toward pro-fibrolysis function and promotes collagen resolution in liver. Cell Mol Gastroenterol Hepatol. 2022;13(5):1483\u2013509.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"3342_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13287-017-0743-7","volume":"8","author":"N Liao","year":"2017","unstructured":"Liao N, Zheng Y, Xie H, Zhao B, Zeng Y, Liu X, et al. Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats. Stem Cell Res Ther. 2017;8(1):286.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"3342_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4252\/wjsc.v10.i11.146","volume":"10","author":"S Nahar","year":"2018","unstructured":"Nahar S, Nakashima Y, Miyagi-Shiohira C, Kinjo T, Toyoda Z, Kobayashi N, et al. Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease. World J Stem Cells. 2018;10(11):146\u201359.","journal-title":"World J Stem Cells"},{"key":"3342_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1054-3589(08)60274-4","volume":"35","author":"I Appleton","year":"1996","unstructured":"Appleton I, Tomlinson A, Willoughby DA. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv Pharmacol (San Diego, Calif). 1996;35:27\u201378.","journal-title":"Adv Pharmacol (San Diego, Calif)"},{"issue":"6","key":"3342_CR60","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/ten.2006.0315","volume":"13","author":"L Cui","year":"2007","unstructured":"Cui L, Yin S, Liu W, Li N, Zhang W, Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng. 2007;13(6):1185\u201395.","journal-title":"Tissue Eng"},{"issue":"9","key":"3342_CR61","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1177\/0963689718780304","volume":"27","author":"FY Yang","year":"2018","unstructured":"Yang FY, Chen R, Zhang X, Huang B, Tsang LL, Li X, et al. Preconditioning enhances the therapeutic effects of mesenchymal stem cells on colitis through PGE2-mediated T-cell modulation. Cell Transplant. 2018;27(9):1352\u201367.","journal-title":"Cell Transplant"},{"issue":"1","key":"3342_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-019-1156-6","volume":"10","author":"L Salda\u00f1a","year":"2019","unstructured":"Salda\u00f1a L, Bensiamar F, Vall\u00e9s G, Mancebo FJ, Garc\u00eda-Rey E, Vilaboa N. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. Stem Cell Res Ther. 2019;10(1):58.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3342_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.327","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao F, Chiu SM, Motan DA, Zhang Z, Chen L, Ji HL, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7(1): e2062.","journal-title":"Cell Death Dis"},{"key":"3342_CR64","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1038\/srep08713","volume":"5","author":"LH Dong","year":"2015","unstructured":"Dong LH, Jiang YY, Liu YJ, Cui S, Xia CC, Qu C, et al. The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2. Sci Rep. 2015;5:8713.","journal-title":"Sci Rep"},{"issue":"10","key":"3342_CR65","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.5966\/sctm.2015-0337","volume":"5","author":"EF Cahill","year":"2016","unstructured":"Cahill EF, Kennelly H, Carty F, Mahon BP, English K. Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis. Stem Cells Transl Med. 2016;5(10):1307\u201318.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"3342_CR66","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-020-01633-7","volume":"11","author":"L Jin","year":"2020","unstructured":"Jin L, Zhang J, Deng Z, Liu J, Han W, Chen G, et al. Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2. Stem Cell Res Ther. 2020;11(1):122.","journal-title":"Stem Cell Res Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03342-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T13:04:24Z","timestamp":1682341464000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03342-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3342"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03342-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed in accordance with the regulations of the ARRIVE guidelines and approved by the Ethics Committee at the Medical College of Qingdao University (Title, Therapeutic effect and molecular mechanisms of TNF-\u03b1\/IL-1\u03b2 pretreated MSCs on liver injury and fibrosis; Approval document of Ethics Committee, Medical College of Qingdao University; Approval Reference No.QDU-AEC-2021165; Date, December 14, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. Qingdao Haier Biotech Co. Ltd. did not provide any product or service to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}